Ritter Pharmaceuticals, Inc.

Inalco S.r.l.

Inalco S.p.a.

Tenagro S.r.l.

Jacopo Chini

Giovanni Cipolletti

Luana Vagnoli

Marco Manoni

Liana Salsini

Giancarlo Tamerlani

Silvia Biagiolini

Silvia Giacomelli

Marina Matulli

Barbara Febbruari

Sonia Spagnesi

The present invention describes a syrup of tagatose and galactose as main components together with other secondary products such as glycerol, oligosaccharides and other sugars in a minority amount.

Tagatose and galactose syrup

The present invention describes a process for the production of (&#x2212;)-cannabidiol (CBD) from industrial hemp by means of an extraction followed by two alternative working processes: a process A which provides extraction with solvents first to an alkaline pH and then to acidic pH to isolate the carboxyl form of the CBD which is then subjected to decarboxylation and a process B which provides the elimination of waxes and pitches and then purification by chromatography. At the end of both alternative working processes the CBD is crystallized obtained in high purity crystalline form.

Method for the production of cannabinoids from types of industrial hemp

The present invention describes a process for preparing ultrapure (&#x2265;95%) galacto-oligosaccharides (GOS), starting from GOS at lower purities by using sequential microbiological purifications involvingand

Process for the production of ultrapure galacto-oligosaccharides

The present invention describes a process for preparing ultrapure (&#x2267;95%) galacto-oligosaccharides (GOS), starting from GOS at lower purities by using sequential microbiological purifications involvingand

The present invention relates to a process for the preparation of sulphated glycosaminoglycans derived from N&#x2014; acetylheparosan which comprises: a) N-deacetylation and N-sulphation of the N-acetylheparosan polysaccharide prepared from natural or recombinant bacterial strain, preferably K5, b) enzymatic epimerization with the glucuronyl C5-epimerase enzyme, c) partial O-sulphation followed by a partial O-desulphation, d) partial 6-O-sulphation, e) N-sulphation and an intermediate step of controlled depolimerization characterised by the fact that both O-sulphations (O-sulphation and 6O-sulphation) are partial. Furthermore the invention relates to the products obtained according to the process which show a ratio between the anti-Xa activity and anti-IIa activity equal to or higher than 1 and to compositions comprising said products in combination with suitable and pharmaceutically acceptable excipients and/or diluent.

Growing community of inventors

Florence, Italy

Jacopo Chini